0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $100 | November 2023
    Product Insights

    Lotus Solar PV Farm

    Lotus Solar PV Farm is a solar PV project located in California, United States. The project is owned by Allianz Global Investors GmbH; Tenaska Energy Inc and was developed by Avantus LLC; Tenaska Energy Inc. The project came online in 2020. Empower your strategies with our Lotus Solar PV Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...

  • Product Insights

    $100 | November 2023
    Product Insights

    Lotus Creek Wind Farm

    Lotus Creek Wind Farm is an Onshore Wind project located in Queensland, Australia. The project is owned by Vestas Development AS and is developed by Lotus Creek Wind Farm Pty Ltd. The project is at the permitting stage. Empower your strategies with our Lotus Creek Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...

  • Product Insights

    $100 | November 2023
    Product Insights

    Lotus Energy Tigray Solar PV Park

    Lotus Energy Tigray Solar PV Park is a solar PV project located in Tigray, Ethiopia. The project is owned and being developed by Lotus Energy Pty Ltd. The project is at the permitting stage. Empower your strategies with our Lotus Energy Tigray Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...

  • Product Insights

    $100 | November 2023
    Product Insights

    Yunnan Huadian Old Lotus Hill Wind Farm

    Yunnan Huadian Old Lotus Hill Wind Farm is an Onshore Wind project located in Yunnan, China. The project is owned and developed by Huadian Fuxin Energy Corp Ltd. The project is currently partially active. Empower your strategies with our Yunnan Huadian Old Lotus Hill Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...

  • Product Insights

    $100 | November 2023
    Product Insights

    Anhui Hefei Feixi Lotus Hill Wind Farm

    Anhui Hefei Feixi Lotus Hill Wind Farm is an Onshore Wind project located in Anhui, China. The project is owned and developed by Concord New Energy Group Ltd. The project came online in 2015. Empower your strategies with our Anhui Hefei Feixi Lotus Hill Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...

  • Company Insights

    $399 | January 2024
    Company Insights

    Innovation and Patenting activity of Lotus Pharmaceutical Co Ltd Q4 2023

    GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Lotus Pharmaceutical Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Amyloid Cardiomyopathy – Drugs In Development, 2023

    Global Markets Direct’s, ‘Amyloid Cardiomyopathy - Drugs In Development, 2023’, provides an overview of the Amyloid Cardiomyopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Amyloid Cardiomyopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Amyloidosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Amyloidosis - Drugs In Development, 2023’, provides an overview of the Amyloidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Lymphoblastic Lymphoma – Drugs In Development, 2023

    Global Markets Direct’s, ‘Lymphoblastic Lymphoma - Drugs In Development, 2023’, provides an overview of the Lymphoblastic Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lymphoblastic Lymphoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Overactive Bladder – Drugs In Development, 2023

    Global Markets Direct’s, ‘Overactive Bladder - Drugs In Development, 2023’, provides an overview of the Overactive Bladder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Overactive Bladder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.